To further confirm the effects of the combination therapy of REMSD and fluoxetine on rats with depression, the expressions of the A1 adenosine receptor, apoptosis- and PI3K/P38 MAPK axis-related proteins, cFos, and ADAR2 were measured by Western blot and qRT-PCR. The gene discussed is MAPK14; the disease is depressive disorder.